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40 MicroRNA target CFTR in DF508 CF airway epithelium
I.K. Oglesby1, S.H. Chotirmall1, C. Greene1, N.G. McElvaney1. 1Royal College
of Surgeons in Ireland, Medicine, Dublin, Ireland
Objectives: Expression of the cystic ﬁbrosis transmembrane conductance regulator
is altered in individuals with the DF508 CFTR mutation. MicroRNA (miRNA)
are differentially expressed in the CF airway epithelium, however their role in
regulation of CFTR expression here remains unexplored. Herein we investigated
the role of up regulated miRNAs in CFTR regulation in vivo in bronchial brushings
from individuals homozygous or heterozygous for DF508 CFTR, validated our
observations in vitro and assessed the impact of defective chloride ion conductance,
genotype and Pseudomonas status on miRNA expression.
Methods:MiRNA target prediction was performed in silico, expression of miRNAs
and target genes was measured by qRT-PCR and/or western blotting. Modulation of
miRNA was carried out using pre-miRs or antagomirs and a luciferase reporter gene
employed to elucidate miRNA/CFTR interaction. MiR-145, -223 and 494 were up
regulated in CF versus non-CF bronchial brushings and cell lines, in DF508 homo-
vs. heterozygotes, in subjects positive for P. aeruginosa and in 16HBE14o− cells
treated with a CFTR inhibitor. Reciprocal down or up regulation of CFTR gene
and/or protein expression was observed following miRNA manipulation and direct
miRNA/target relationship demonstrated via a luciferase reporter system containing
the full length 3’-untranslated region of CFTR.
Conclusions: Increased expression of miR-145, -223 and -494 in vivo in bronchial
epithelium of individuals carrying the DF508 CFTR mutation correlates with de-
creased CFTR expression. Defective CFTR function and Pseudomonas colonisation
may affect miRNA expression and contribute to the regulation of DF508 CFTR
mutation.
41 Corrector effect of resveratrol on refractory adrenergic pathway in
saliva secretion of cystic ﬁbrosis mice
C. Bouckaert1, S. Noel1, A. Palem1, P. Lebecque2, P. Wallemacq1, T. Leal1.
1Universite´ Catholique de Louvain, Louvain Center for Toxicology and Applied
Pharmacology (LTAP), Brussels, Belgium; 2Cliniques Universitaires St Luc,
Pediatric Pulmonology & Cystic Fibrosis, Brussels, Belgium
Objectives: Antioxidant and anti-inﬂammatory properties have being claimed for
resveratrol, a polyphenol found in plant foods; thus we raised the hypothesis that
this compound would have beneﬁcial effects in CF.
Methods: We tested the effect of resveratrol (50mg/kg) or vehicle, applied once-
daily by intraperitoneal injection, during 4 days, on constitutive and b-adrenergic
stimulated saliva secretion in F508del-CFTR (CF) and wild-type (WT) mice. A
salivary secretion test was performed 2 h after resveratrol or vehicle injection on
day 2 and 4. The basal, constitutive contribution of b-adrenergic pathway of saliva
secretion ﬂow (SSF; mg/min/g body weight), assessed after blocking the cholinergic
pathway with local 10−3 M atropine, was signiﬁcantly reduced in untreated CF
mice compared to WT mice (median [range] SSF 4.8 [2.4−8.1] mg/min/g in female
CF); values in WT mice were at least twice higher (p = 0.037; Wilcoxon test). As
expected, b-agonist 10−4 M isoprenaline stimulation produced a dramatic increase
in WT SSF. In contrast, no detectable change was seen in CF mice. Resveratrol
treatment removed the refractory effect of CF b-agonist response by increasing SSF
by at least 3-fold in female mice; a trend being observed in male mice.
Conclusion: These data conﬁrm that b-adrenergic pathway of saliva secretion is
reduced in CF mice and indicate that resveratrol rescues CFTR-dependent refractory
adrenergic pathway of saliva secretion in CF mice.
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B. Tu¨mmler1. 1MHH, Hannover, Germany
Introduction: Only few studies have yet described immunoblot analysis of CFTR in
human tissue. In the context of the upcoming studies on correctors and potentiators
of mutant CFTR the quantitation of the amount of detected CFTR protein is a
critical parameter to examine the function of the correctors and potentiators by
immunoblot analysis. CFTR is expressed at the apical membrane of epithelial cells.
CFTR immunoblot analysis should be performed in tissues that are most afﬂicted
in CF, i.e. airways and the intestine. Of the many possible options, the analysis of
rectal tissue is most suitable, because the excision of rectal tissue is safe, painless
and repeatable, which is important for studies with correctors and potentiators.
As apical epithelial marker proteins for rectal biopsies sucrase-isomaltase, villin
and chloride channel 2 were chosen.
Objectives: To quantify the amount of detected CFTR protein as this is the critical
parameter.
Methods: The three candidates and CFTR were tested in rectal biopsies from non-
CF volunteers. Signal intensity of all three proteins was reliable, but the chloride
channel 2 showed cross reactivity to the used secondary antibodies. Villin and
sucrase-isomaltase were evaluated as useful marker proteins for the quantitation
of CFTR isolated from rectal biopsies. Because the immunoblot analyses can be
done from tissue, which had been examined before by ICM (intestinal current
measurement), protein analyses can be combined with functional analyses of the
correctors and potentiators on the same tissue specimen.
Conclusion: In conclusion, villin and sucrase-isomaltase are suited marker proteins
for quantitation of CFTR immunoreactive signals.
